Medications for Opioid Use Disorder Utilization Among Oxford House Residents

Majer, John M.; Jason, Leonard A.; Norris, Joshua; Hickey, Patrick; Jeong, Hayoung; Bobak, Ted J.

doi:10.1007/s10597-020-00558-y

Cited by 7 publications

(3 citation statements)

References 24 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Recent studies on attitudes toward MAT in OH demonstrate some negative attitudes toward individuals utilizing MAT, even among those currently prescribed MAT (Majer et al, 2018). OH residents' attitudes were more favorable toward individuals prescribed MAT when living with them (Majer, Jason, Norris, et al, 2020). OHs have been found to assist individuals prescribed MAT develop social support networks, which increases abstinence self‐efficacy (Majer, Jason, Hickey, et al, 2020).…”

Section: Introductionmentioning

confidence: 99%

“…Research on their entry into recovery homes, specifically Oxford House (OH), is sparse. Several studies have examined the history of MAT, the attitudes toward it, opinions on how to manage treatment, and differing attitudes toward MAT use as a method for recovery (Joseph et al, 2000; Joseph & Woods, 2018; Majer et al, 2018; Majer, Jason, Hickey, et al, 2020; Majer, Jason, Norris, et al, 2020). Presently, there are no studies that have examined the lived experiences of individuals entering recovery homes while using MAT.…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Lived experiences of Oxford House residents prescribed medication‐assisted treatment

Soto-Nevarez

Abo

Mackenzie

et al. 2023

Journal Community Psychology

Self Cite

View full text Add to dashboard Cite

Qualitative studies have examined the recovery experiences of individuals prescribed medication‐assisted treatment (MAT), including their experiences within treatment facilities. However, the literature lacks qualitative studies exploring the recovery process of individuals prescribed MAT while living in recovery housing, such as Oxford House (OH). The purpose of this study was to explore how OH residents, who are prescribed MAT, make sense of recovery. The fact that OHs are drug‐free recovery housing is what makes the issue of using MATs potentially contentious in these settings. Interpretative phenomenological analysis (IPA) was used to document the lived experiences of individuals prescribed MAT in OH. The sample included: five women and three men, prescribed either methadone or Suboxone, that were living in an OH in the United States. Participants were interviewed on four topics: their recovery process, their transition to OH, and their experience living in and outside of an OH. Analysis of results followed the recommendations for IPA from Smith, Flowers, and Larkin. Four general themes emerged from the data: Recovery Process, Managing Logistics of MAT Utilization, Personal Development, and Familial Values. In conclusion, individuals prescribed MAT did benefit from living in an OH to manage their recovery as well as stay compliant with their medication.

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Lived experiences of Oxford House residents prescribed medication‐assisted treatment

Soto-Nevarez

Abo

Mackenzie

et al. 2023

Journal Community Psychology

Self Cite

View full text Add to dashboard Cite

show abstract

“…Oxford Houses are recovery homes that have been researched most extensively [Substance Abuse and Mental Health Services Administration (SAMHSA), 2020], and they provide community-based therapeutic support that can help persons utilizing MAT in their recovery. A recent investigation found mostly favorable attitudes toward fellow residents who utilized MAT in addition to comparable rates of abstinence, lengths of stay in Oxford Houses and 12-step involvement between residents who utilized and did not utilize MAT (Majer et al , 2020), and research evidence suggests social embeddedness is related to residents’ quality of life (Doogan et al , 2019; Jason et al , 2020). However, Oxford House residents typically attend 12-step groups where some 12-step peers’ dissonant views toward MAT create a stressor among residents who utilize MAT (Monico et al , 2015; Suzuki & Dodds, 2016) that could diminish recovery gains and differences in residents’ approach to recovery in relation to medication use could result in disparate experiences that influence residents’ homophily.…”

Section: Introductionmentioning

confidence: 99%

Psychiatric severity and stress among recovery home residents utilizing medication assisted treatment: a moderated mediation analysis of homophily

Majer

Bobak

Jason

2021

ADD

Self Cite

View full text Add to dashboard Cite

Purpose The purpose of this study is to examine the relationship between psychiatric severity and stress among persons utilizing medication assisted treatment (MAT), and there is a need to identify resources that promote resilience against these risk factors. Although recovery homes might complement pharmacological interventions for persons using MAT, a lack of homophily (e.g. similar experiences) among residents could produce stress and increase psychiatric severity. The purpose of this paper is to examine stress and psychiatric severity in relation to recovery outcomes, and whether homophily moderated these relationships. Design/methodology/approach A cross-sectional analysis was conducted among recovery home residents who were recruited from the USA, including those using (n = 40) and not using (n = 132) MAT. Participants’ levels of psychiatric severity, stress, abstinence self-efficacy and quality of life were assessed in addition to whether residents using MAT were living with at least one other resident who used MAT. Moderated mediation analyses were conducted to examine whether homophily among residents using MAT would moderate the mediating effects of stress on the relationships between psychiatric severity and recovery outcomes (abstinence-self efficacy, quality of life). Findings Mediating effects were observed but they were significant only through homophily. Although stress increased the negative effects of psychiatric severity among residents using MAT, significantly lesser effects were observed among those living with residents using MAT. Practical implications Although psychiatric (problem) severity and stress threaten recovery for persons with substance use disorders, little is known how they impact recovery among those living in community-based settings such as recovery homes. In addition, there is a need to identify community resources that would complement MAT protocols, as patients who use MAT face unique stressors related to their sense of shared interests and experiences (i.e. homophily) when developing social bonds with others in recovery. Social implications This study suggests the social networks within recovery homes reduce the effects of psychiatric severity and stress, and that these effects are lessened for residents who use MAT when they live with others who also use MAT. Originality/value Little is known about recovery home residents who use MAT and have high psychiatric severity. Findings suggest homophily among persons using MAT living in recovery homes who have high psychiatric severity can promote resilience.

show abstract

Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers

Mahone,

Enich,

Treitler

et al. 2023

The American Journal of Drug and Alcohol Abuse

View full text Add to dashboard Cite

Medications for Opioid Use Disorder Utilization Among Oxford House Residents

Cited by 7 publications

References 24 publications

Lived experiences of Oxford House residents prescribed medication‐assisted treatment

Lived experiences of Oxford House residents prescribed medication‐assisted treatment

Psychiatric severity and stress among recovery home residents utilizing medication assisted treatment: a moderated mediation analysis of homophily

Opioid use disorder treatment and the role of New Jersey Medicaid policy changes: perspectives of office-based buprenorphine providers

Contact Info

Product

Resources

About